207 related articles for article (PubMed ID: 36166443)
1. Healthcare resource utilization in patients with treatment-resistant depression-A Danish national registry study.
Jensen KJ; Gronemann FH; Ankarfeldt MZ; Jimenez-Solem E; Alulis S; Riise J; Bødker N; Osler M; Petersen J
PLoS One; 2022; 17(9):e0275299. PubMed ID: 36166443
[TBL] [Abstract][Full Text] [Related]
2. Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?
Pilon D; Sheehan JJ; Szukis H; Morrison L; Zhdanava M; Lefebvre P; Joshi K
J Affect Disord; 2019 Aug; 255():50-59. PubMed ID: 31128505
[TBL] [Abstract][Full Text] [Related]
3. Use of home health and other healthcare delivery pathways among privately insured patients with and without treatment-resistant depression.
Pilon D; Szukis H; Singer D; Morrison L; Sheehan JJ; Lefebvre P
Curr Med Res Opin; 2020 May; 36(5):865-874. PubMed ID: 31985319
[No Abstract] [Full Text] [Related]
4. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
[TBL] [Abstract][Full Text] [Related]
5. Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions.
Zhdanava M; Kuvadia H; Joshi K; Daly E; Pilon D; Rossi C; Morrison L; Lefebvre P; Nelson C
J Manag Care Spec Pharm; 2020 Aug; 26(8):996-1007. PubMed ID: 32552362
[TBL] [Abstract][Full Text] [Related]
6. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
[TBL] [Abstract][Full Text] [Related]
7. Economic burden of treatment-resistant depression among veterans in the United States.
Szukis H; Joshi K; Huang A; Amos TB; Wang L; Benson CJ
Curr Med Res Opin; 2021 Aug; 37(8):1393-1401. PubMed ID: 33879005
[TBL] [Abstract][Full Text] [Related]
8. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorder.
Zhdanava M; Kuvadia H; Joshi K; Daly E; Pilon D; Rossi C; Morrison L; Lefebvre P; Nelson C
Curr Med Res Opin; 2021 Jan; 37(1):123-133. PubMed ID: 33124940
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel.
Sharman Moser S; Chodick G; Gelerstein S; Barit Ben David N; Shalev V; Stein-Reisner O
BMC Psychiatry; 2022 Aug; 22(1):541. PubMed ID: 35948895
[TBL] [Abstract][Full Text] [Related]
11. Economic Burden of Treatment-Resistant Depression on the U.S. Health Care System.
Sussman M; O'sullivan AK; Shah A; Olfson M; Menzin J
J Manag Care Spec Pharm; 2019 Jul; 25(7):823-835. PubMed ID: 31232205
[TBL] [Abstract][Full Text] [Related]
12. Economic Burden of Treatment-Resistant Depression among Adults with Chronic Non-Cancer Pain Conditions and Major Depressive Disorder in the US.
Shah D; Allen L; Zheng W; Madhavan SS; Wei W; LeMasters TJ; Sambamoorthi U
Pharmacoeconomics; 2021 Jun; 39(6):639-651. PubMed ID: 33904144
[TBL] [Abstract][Full Text] [Related]
13. An Evaluation of the Clinical and Economic Burden Among Older Adult Medicare-Covered Beneficiaries With Treatment-Resistant Depression.
Benson C; Szukis H; Sheehan JJ; Alphs L; Yuce H
Am J Geriatr Psychiatry; 2020 Mar; 28(3):350-362. PubMed ID: 31735488
[TBL] [Abstract][Full Text] [Related]
14. Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.
Amos TB; Tandon N; Lefebvre P; Pilon D; Kamstra RL; Pivneva I; Greenberg PE
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474009
[TBL] [Abstract][Full Text] [Related]
15. Prospective Service Use and Health Care Costs of Medicaid Beneficiaries with Treatment-Resistant Depression.
Olfson M; Amos TB; Benson C; McRae J; Marcus SC
J Manag Care Spec Pharm; 2018 Mar; 24(3):226-236. PubMed ID: 29485948
[TBL] [Abstract][Full Text] [Related]
16. Medicaid spending burden among beneficiaries with treatment-resistant depression.
Pilon D; Sheehan JJ; Szukis H; Singer D; Jacques P; Lejeune D; Lefebvre P; Greenberg PE
J Comp Eff Res; 2019 Apr; 8(6):381-392. PubMed ID: 30734581
[TBL] [Abstract][Full Text] [Related]
17. Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder.
Gronemann FH; Petersen J; Alulis S; Jensen KJ; Riise J; Ankarfeldt MZ; Solem EJ; Bødker N; Osler M
J Affect Disord; 2021 May; 287():204-213. PubMed ID: 33799039
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Relationship Between Depression Symptom Severity and Health Care Costs for Patients With Treatment-Resistant Depression.
Lynch FL; Dickerson JF; O'Keeffe-Rosetti M; Chow W; Pesa J
J Clin Psychiatry; 2022 Feb; 83(2):. PubMed ID: 35120286
[No Abstract] [Full Text] [Related]
19. Comorbidity and healthcare utilization in patients with treatment resistant depression: A large-scale retrospective cohort analysis using electronic health records.
Adekkanattu P; Olfson M; Susser LC; Patra B; Vekaria V; Coombes BJ; Lepow L; Fennessy B; Charney A; Ryu E; Miller KD; Pan L; Yangchen T; Talati A; Wickramaratne P; Weissman M; Mann J; Biernacka JM; Pathak J
J Affect Disord; 2023 Mar; 324():102-113. PubMed ID: 36529406
[TBL] [Abstract][Full Text] [Related]
20. A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.
Li G; Zhang L; DiBernardo A; Wang G; Sheehan JJ; Lee K; Reutfors J; Zhang Q
PLoS One; 2020; 15(9):e0238843. PubMed ID: 32915863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]